Coagulopathy in the ER: All Bleeding Stops Eventually.
Upon completion of this session, the participant should be able to: COMP, EBM
- Differentiate different patterns of coagulopathy that present to the ED.
- Develop an evaluation and treatment plan for non-traumatic bleeding disorders in the ED, including hemophilia, TTP, ITP and others.
- Outline the rationale and indications for the use of blood products used in the treatment of the bleeding patient.
- Discuss some of the newer anticoagulation agents used today, such as Prasugrel (Effient) and Dabigatran (Pradaxa), as per thr referenced RCT’s and EBM studies such as Rocket, RE-LY and Einstein.
Drug-Drug Interactions (DDIs).
Upon completion of this session, the participant should be able to: COMP, GL
- Assess the scope of the problem of drug-drug interactions as it pertains to both the outpatient and emergency settings.
- Explore interactions between prescription and non-prescription medications and review their treatments in the context of the Beers Criteria.
- Review common drug-drug interactions and their complications commonly seen in the emergency room.
As the World Turns: Peripheral Vertigo in the ED.
Upon completion of this session, the participant should be able to: COMP^
- Illustrate the pathophysiology of benign positional vertigo.
- Differentiate the various diagnostic tests in the evaluation of patients with peripheral vertigo.
- Discover how to perform various therapeutic maneuvers, such as the Epley maneuver, in the treatment of patients with benign positional vertigo.
The Opioid Epidemic: How We Got Here and How We’re Going to Dig Ourselves Out.
Upon completion of this session, the participant should be able to: GL, EBM, COMP
- Apply the CDC guidelines for Prescribing Opioids in Chronic Pain with regards to duration of treatment when prescribing opioids upon ED discharge.
- Recognize the core reasons the opioid epidemic is most severe in the United States and less severe in most other countries.
- Utilize the combination of ibuprofen and acetaminophen instead of opioids when treating acute extremity pain as based on a study published in JAMA in November 2017.